STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Clinical trials for STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton vs. photon: which radiation beats lung cancer best?
Disease control OngoingThis study compares two types of radiation therapy (proton and photon) combined with chemotherapy for people with stage II-IIIB non-small cell lung cancer that cannot be surgically removed. The goal is to see which approach helps patients live longer and causes fewer side effects…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Lung cancer radiation gets a precision boost: trial aims to hit tumors harder, spare healthy tissue
Disease control OngoingThis study tests whether giving a higher radiation dose directly to the tumor, while keeping the standard dose to surrounding healthy tissue, can improve outcomes for people with stage II to IIIB non-small cell lung cancer. About 146 participants will receive either photon (IMRT)…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Targeted pill after surgery may keep ALK lung cancer from returning
Disease control OngoingThis study looks at whether taking crizotinib after surgery can help people with early-stage ALK-positive non-small cell lung cancer live longer without the cancer coming back. About 166 patients who had their tumor removed will either take crizotinib pills or just be watched. Th…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC